# Relay Therapeutics, Inc.: Form 8-K, filed Jun 3, 2024

- Company: [Relay Therapeutics, Inc.](/companies/rlay.md) (CIK 1812364)
- Form: 8-K
- Filed: 2024-06-03
- Accepted by EDGAR: Jun 3, 2024, 16:05 ET
- Period: 2024-06-03
- Accession: 0000950170-24-067952
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1812364/000095017024067952/rlay-20240603.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1812364/000095017024067952/

## Items reported

- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1812364/000095017024067952/rlay-20240603.htm

Filed Jun 3, 2024.
Source: SEC EDGAR, the filing index for accession 0000950170-24-067952. Last ingested by Listed: Oct 30, 2026, 16:27 ET. No prices; not investment advice.